Many First Nations communities face a disproportionate demand for specialized rare disease care and early identification is essential for timely treatment and life planning.

Apply today to attend the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting in May 2026.

Earlier this month, the RareKids-CAN community came together to connect, collaborate, and learn—both in person in Ottawa and virtually from coast to coast to coast and beyond! It was incredible to see so many familiar faces and to welcome new members, all united in our shared commitment to advancing pediatric rare disease clinical trials and treatments in Canada.